$OSIP OSI PHARMACEUTICALS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OSI PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in OSI PHARMACEUTICALS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
OSI PHARMACEUTICALS INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| AMPER LINDA E | VP Bus. Administration & HR | 10 | 0 | Apr 19 2005 | |||
| AMPER LINDA E | Sr. VP, Human Resources | 19,101 | 0 | Mar 03 2010 | |||
| AMPER LINDA E | Sr. VP, Human Resources | 0 | 0 | Jun 07 2010 | |||
| Astellas Pharma Inc. | 10% Owner | 57,232,357 | 0 | Jun 09 2010 | |||
| ATIEH MICHAEL G | Exec. VP & CFO | 28,311 | 0 | Oct 24 2005 | |||
| ATIEH MICHAEL G | Exec. VP & CFO | 31,897 | 0 | Dec 16 2008 | |||
| BROWNE G MORGAN | Director | 24,855 | 0 | Mar 18 2005 | |||
| BROWNE G MORGAN | Director | 26,203 | 0 | May 23 2007 | |||
| CAGNONI PABLO J | VP & Chief Medical Officer | 6,710 | 0 | Dec 15 2006 | |||
| COSTA SANTO J | Director | 14,000 | 0 | Jun 19 2009 | |||
| COSTA SANTO J | Director | 0 | 0 | Jun 09 2010 | |||
| Davies Angela M. | Sr. VP and CMO, Oncology | 0 | 0 | Jun 09 2010 | |||
| Epstein David M. | Sr. VP and CSO, Oncology | 13,340 | 0 | May 04 2010 | |||
| Epstein David M. | Sr. VP and CSO, Oncology | 0 | 0 | Jun 09 2010 | |||
| FRENCH JOHN H II | Director | 2,497 | 0 | Mar 04 2004 | |||
| GEE EDWIN A | Director | 3,555 | 0 | Aug 16 2004 | |||
| GIBSON NEIL | Vice President Research | 3,280 | 0 | May 06 2005 | |||
| GIBSON NEIL | Sr. VP & CSO | 15,250 | 0 | Dec 14 2007 | |||
| GODDARD COLIN | Chief Executive Officer | 58,573 | 0 | Oct 24 2005 | |||
| GODDARD COLIN | Chief Executive Officer | 158,265 | 0 | Mar 03 2010 | |||
| GODDARD COLIN | Chief Executive Officer | 0 | 0 | Jun 09 2010 | |||
| GRANNER DARYL K | Director | 9,948 | 0 | Oct 26 2005 | |||
| GRANNER DARYL K | Director | 16,537 | 0 | Feb 05 2009 | |||
| GUYER DAVID R | Exec. VP & CEO (OSI) Eyetech | 3,682 | 0 | Dec 02 2005 | |||
| INGRAM ROBERT ALEXANDER | Director | 29,886 | 0 | Jun 19 2009 | |||
| INGRAM ROBERT ALEXANDER | Director | 0 | 0 | Jun 09 2010 | |||
| INGRAM ROBERT ALEXANDER | Director | 14,693 | 0 | Oct 31 2005 | |||
| KLEIN JOSEPH III | Director | 5,000 | 0 | Feb 02 2010 | |||
| KLEIN JOSEPH III | Director | 0 | 0 | Jun 09 2010 | |||
| LEE KENNETH B JR | Director | 0 | 0 | Jun 07 2010 | |||
| LEE KENNETH B JR | Director | 11,500 | 0 | Jun 19 2009 | |||
| Legault Pierre | Exec. VP, CFO & Treasurer | 22,049 | 0 | Jan 04 2010 | |||
| Legault Pierre | Exec. VP, CFO & Treasurer | 0 | 0 | Jun 07 2010 | |||
| LEUNG GABRIEL | Exec. VP, Pres., Oncology Bus. | 10,429 | 0 | Jun 17 2005 | |||
| LEUNG GABRIEL | EVP & Pres. Pharma. Business | 38,324 | 0 | Mar 03 2010 | |||
| LEUNG GABRIEL | EVP & Pres. Pharma. Business | 0 | 0 | Jun 09 2010 | |||
| LOVENBERG WALTER M PHD | Director | 12,874 | 0 | Oct 27 2005 | |||
| LOVENBERG WALTER M PHD | Director | 20,182 | 0 | Mar 02 2007 | |||
| LOVERBERG WALTER | Director | 8,052 | 0 | Mar 19 2004 | |||
| LUNDEMOSE ANKER MD, PH.D, DSC | Exec. VP & Pres. OSI Prosidion | 15,068 | 0 | Oct 24 2005 | |||
| LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & Strategic Pln | 30,623 | 0 | Mar 03 2010 | |||
| LUNDEMOSE ANKER MD, PH.D, DSC | EVP, Corp. Dev & Strategic Pln | 0 | 0 | Jun 09 2010 | |||
| MEHTA VIREN | Director | 77,754 | 0 | Oct 24 2005 | |||
| MEHTA VIREN | Director | 86,251 | 0 | Jun 19 2009 | |||
| MEHTA VIREN | Director | 0 | 0 | Jun 09 2010 | |||
| NIEMIEC DAVID W | Director | 24,000 | 0 | Jun 19 2009 | |||
| NIEMIEC DAVID W | Director | 0 | 0 | Jun 09 2010 | |||
| ONETTO NICOLE | Exec.VP& Chief Medical Officer | 4,544 | 0 | Apr 19 2005 | |||
| PINEDO HERBERT MD PHD | Director | 1,970 | 0 | Mar 18 2005 | |||
| PINEDO HERBERT MD PHD | Director | 2,467 | 0 | Mar 20 2006 | |||
| PINEDO HERBERT MD PHD | Director | 10,467 | 0 | Jun 19 2009 | |||
| PINEDO HERBERT MD PHD | Director | 0 | 0 | Jun 09 2010 | |||
| Rachman Jonathan | Sr VP, Diabetes/Obesity R&D | 14,402 | 0 | Dec 18 2009 | |||
| Rachman Jonathan | Sr VP, Diabetes/Obesity R&D | 0 | 0 | Jun 07 2010 | |||
| RICHMOND MARK | Director | 3,575 | 0 | Aug 03 2005 | |||
| RICHMOND MARK | Director | 5,323 | 0 | Jul 18 2006 | |||
| SIMON ROBERT L | Exec. VP, Pharm. Dev. Tech. Op | 7,550 | 0 | Oct 28 2005 | |||
| SIMON ROBERT L | EVP, Pharmaceut. & Tech. Ops | 40,368 | 0 | Dec 18 2009 | |||
| SIMON ROBERT L | EVP, Pharmaceut. & Tech. Ops | 0 | 0 | Jun 09 2010 | |||
| STEVENSON KATHARINE BERGHUIS | Director | 3,133 | 0 | Oct 24 2005 | |||
| STEVENSON KATHARINE BERGHUIS | Director | 11,490 | 0 | Jun 19 2009 | |||
| STEVENSON KATHARINE BERGHUIS | Director | 0 | 0 | Jun 09 2010 | |||
| VAN NOSTRAND ROBERT L | VP, & Chief Financial Officer | 4,899 | 0 | May 03 2005 | |||
| WHITE JOHN P | Director | 19,075 | 0 | Oct 25 2005 | |||
| WHITE JOHN P | Director | 18,323 | 0 | Jun 19 2009 | |||
| WHITE JOHN P | Director | 0 | 0 | Jun 09 2010 | |||
| WOOD BARBARA A | V.P. & General Counsel | 7,433 | 0 | Oct 24 2005 | |||
| WOOD BARBARA A | Sr. V.P. & General Counsel | 27,366 | 0 | Mar 03 2010 | |||
| WOOD BARBARA A | Sr. V.P. & General Counsel | 0 | 0 | Jun 09 2010 |